Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

More documents

Recommendations

Info

APPENDIX 9. Healthcare Research Centres (cont’d) RESEARCH CENTRE/ URL CONTACT DESCRIPTION Children’s Health Policy Centre (CHPC) www.childhealthpolicy.sfu.ca 270 CHPC is an interdisciplinary research group in the Faculty of Health Sciences at Simon Fraser University. CHPC focus is on integrating research and policy to improve children’s social and emotional well-being or children’s mental health. CHPC work complements the mission of the Faculty of Health Sciences to integrate research and policy for population and public health locally, nationally and globally. CHPC have prepared systematic reviews of the best available research evidence on the prevention and treatment of children’s mental disorders. • Treating Concurrent Substance Use and Mental Disorders in Children and Youth • Preventing Substance Use Disorders in Children and Youth • Preventing and Treating Childhood Sexual Abuse • Mental Health and Developmental Disabilities in Children • Implementing Evidence-Based Practice in Children’s Mental Health • Preventing and Treating Obsessive-Compulsive Disorder in Children and Youth • Preventing and Treating Eating Disorders in Children and Youth • Preventing Suicide in Youth: Taking Action With Imperfect Knowledge • The Mental Health and Well-Being of Aboriginal Children and Youth: Guidance for New Approaches and Services • Preventing and Treating Depression in Children and Youth • Early Psychosis: A Review of the Treatment Literature • Preventing and Treating Anxiety Disorders in Children and Youth • Preventing and Treating Conduct Disorder in Children and Youth • Child and Youth Mental Health Research Reports: Prevalence of Mental Disorders in Children and Youth • Child and Youth Mental Health Research Reports: Draft Practice Parameters Faculty of Health Sciences, Simon Fraser University Room 2435, 515 West Hastings Street Vancouver, B.C. V6B 5K3 CHPC Director: Charlotte Waddell Tel: 778-782-7769 charlotte_waddell@sfu.ca Contact: Brigitte Bennetsen, Office Manager Tel: 778-782-7775 Fax: 778-782-7777 chpc@sfu.ca • Child and Youth Mental Health Research Reports: Population Health and Clinical Service Considerations. Department of Pediatrics (DOP) UBC www.pediatrics.med. ubc.ca BRITISH COLUMBIA DOP of UBC and B.C.’s Children’s Hospital consists of physicians, scientists, allied health professionals and administrative staff trained in pediatric and allied child health disciplines. DOP mandate is to provide leadership and excellence in the following areas: Patient Care, Education, Research and Child Advocacy. DOP continues to work towards being a cohesive academic and professional body committed to the advancement of betterment of child health care through the delivery of exemplary patient care, teaching and research. DOP core facilities support development of a broad range of basic and clinical research initiatives. Infection and immunity is a particular strength with an outstanding research program that spans transplantation to immunization. DOP Paediatric Oncology Research Program is an area of strength with major donor commitments. Understanding influences on early development and the interface between biology, behaviour and the environment is an area of strength. Epigenetics is a developing major area of research that is shared by numerous divisions. DOP Clinical Research Support Unit (CRSU) supports academic research in the domains of clinical, health services and population health and works with the divisions to improve the organization and delivery of quality health care and to promote patients’ safety. DOP leads a national network aimed at identifying the genomic profile of patients who develop serious drug related events. UBC Faculty of Medicine Room 2D19, 4480 Oak Street B.C. Children’s Hospital Vancouver, B.C. V6H 3V4 Tel: 604-875-3177 Fax: 604-875-2890 Department Head: Robert Armstrong Contact: Marcelle Sprecher, Acting Director of Administration msprecher@cw.bc.ca
RESEARCH CENTRE/ URL CONTACT DESCRIPTION CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP MCS is a small non-profit organization concerned with the health of young people in B.C.. MCS has conducted community-based research and projects addressing current youth health issues. The society takes its name from the late Dr. J.F. McCreary, a paediatrician and medical administrator, whose leadership in promoting inter-professional teaching and multi-disciplinary approaches in health care set a standard that the society seeks to emulate. MCS has a number of partnerships to develop research and networking opportunities, including: • Student Research Group • Sexual Orientation, Risk and Resilience Study • Experiences of Stigma and Risk Behaviours Study MCS research is in early adolescence, youth homelessness and youth vulnerability: • Promoting Resiliency in Early Adolescence • Healthy Youth Development: The Opportunity of Early Adolescence • National Training Initiative in Adolescent Health (NTIAH) • Violence in Adolescence: injury, suicide, and criminal violence in the lives of B.C. youth • Accenting the Positive: a developmental framework for reducing risk and promoting positive outcomes among B.C. youth. 3552 Hastings Street E. Vancouver, B.C. V5K 2A7 Tel: 604-291-1996 Fax: 604-291-7308 mccreary@mcs.bc.ca Executive Director: Annie Smith Contact: Elizabeth Saewyc, Research Director The McCreary Centre Society (MCS) www.mcs.bc.ca 10. WOMEN’S HEALTH RESEARCH CENTRES BCCEWH research has been framed by three themes: Healthy Women and Healthy Communities, Health Status and Health Determinants, Women Centred Care. BCCEWH current activities focus on women and addictions; mental health; health services; mothering and maternity; and physical activity. BCCEWH collaborates with women’s health researchers across B.C., across Canada and around the world. The BCCEWH is known internationally for its work on women tobacco issues, as well as change-oriented research and knowledge exchange activities. E311 – 4500 Oak Street, Box 48 Vancouver, B.C. V6H 3N1 Tel: 604-875-2633 Toll free: 1-888-300-3088 ext. 2633 Fax: 604-875-3716 bccewh@cw.bc.ca Contact: Ginny Gonneau Research Co-ordinator B.C. Centre of Excellence for Women’s Health (BCCEWH) www.bccewh.bc.ca ggonneau@cw.bc.ca Centre for Menstrual Cycle and Ovulation Research (CeMCOR) www.cemcor.ubc.ca 271 CeMCOR is an accessible research centre with a mandate to distribute information directly to women about changes through the life cycle, from adolescence to menopause. CeMCOR’S goal is to do good science that honours the voices and experiences of women. It is the only centre in North America that focuses on ovulation and the causes for and consequences of ovulation disturbances. CeMCOR studies the physical and psychological causes and effects of ovulation disturbances on women’s overall health. CeMCOR publishes scientific results and disseminates information directly to women. CeMCOR document variations in the menstrual cycle and ovulation in the context of the lives of women of all ages. CeMCOR is analyzing the relationships of the menstrual cycle and ovulation changes with weight changes, metabolism changes, eating attitudes, breast maturation, bone physiology, pre-menstrual experiences and changes in the physiology of exercise, respiration, cardiovascular function and breast density and nodularity. The Gordon and Leslie Diamond Health Care Centre Room 4111 - 4th Floor 2775 Laurel Street, Vancouver B.C. V5Z 1M9 Tel: 604–875-5927 Fax: 604-875-5915 cemcor@interchange.ubc.ca Jerilynn C. Prior, Scientific Director
Page 1:
1 33 0 34 0 M A G N E T I C V A R 9
Page 4 and 5:
ii BRITISH COLUMBIA
Page 6 and 7:
2 EXECUTIVE SUMMARY BRITISH COLUMBI
Page 8 and 9:
4 INTRODUCTION BRITISH COLUMBIA Wit
Page 10 and 11:
6 Health Authority (URL) Key Facili
Page 12 and 13:
8 FIGURE 2. Clinical Trials Units,
Page 14 and 15:
10 Facility (URL if available) Pedi
Page 16 and 17:
12 Facility (URL if available) Mood
Page 18 and 19:
14 Facility (URL if available) Down
Page 20 and 21:
16 Facility (URL if available) Clin
Page 22 and 23:
18 Facility (URL if available) Gast
Page 24 and 25:
20 TABLE 3. Clinical Trials Support
Page 26 and 27:
22 Much clinical research - particu
Page 28 and 29:
24 FIGURE 3. Source of Funds for Cl
Page 30 and 31:
26 BRITISH COLUMBIA FIGURE 7. Thera
Page 32 and 33:
28 BRITISH COLUMBIA Clinical Invest
Page 34 and 35:
Disease Area Population Information
Page 36 and 37:
32 CV/Cardiology CNS Pulmonary Canc
Page 38 and 39:
34 TABLE 9. Health Economics and He
Page 40 and 41:
36 TABLE 10. Epidemiology and Surve
Page 42 and 43:
38 TABLE 12. Provincial Networks Th
Page 44 and 45:
40 Network B.C. Investigator’s Ro
Page 46 and 47:
42 Network B.C. Investigator’s Ro
Page 48 and 49:
44 TABLE 14. Independent Clinical T
Page 50 and 51:
46 COMPARATIVE POSITIONING OF B.C.
Page 52 and 53:
48 ACKNOWLEDGEMENTS BRITISH COLUMBI
Page 54 and 55:
50 APPENDIX 1-2 TABLE OF CONTENTS B
Page 56 and 57:
52 PROVINCIAL HEALTH SERVICES AUTHO
Page 58 and 59:
54 BRITISH COLUMBIA Edward Miller C
Page 60 and 61:
56 BRITISH COLUMBIA Radiation Thera
Page 62 and 63:
58 The Unit has 15 Principal Invest
Page 64 and 65:
60 BRITISH COLUMBIA Neonatal Resear
Page 66 and 67:
62 The B.C. Children’s Hospital p
Page 68 and 69:
64 BRITISH COLUMBIA The clinical tr
Page 70 and 71:
66 FRASER HEALTH AUTHORITY BRITISH
Page 72 and 73:
68 BRITISH COLUMBIA tional therapis
Page 74 and 75:
70 PROVIDENCE HEALTH CARE SOCIETY 4
Page 76 and 77:
72 BRITISH COLUMBIA Quality control
Page 78 and 79:
74 Clinical trials investigators in
Page 80 and 81:
76 The facility has 13 investigator
Page 82 and 83:
78 Staffing of the Centre is as fol
Page 84 and 85:
80 Investigators: • Ayas, Najib
Page 86 and 87:
82 BRITISH COLUMBIA Quality control
Page 88 and 89:
84 The Research Group consists of t
Page 90 and 91:
86 BRITISH COLUMBIA Multiple Sclero
Page 92 and 93:
88 BRITISH COLUMBIA Gastroenterolog
Page 94 and 95:
Since the Centre is located in St.
Page 96 and 97:
TABLE A1. Providence Health Care So
Page 98 and 99:
94 BRITISH COLUMBIA FIGURE A9. Cent
Page 100 and 101:
96 BRITISH COLUMBIA The Unit suppor
Page 102 and 103:
TABLE A2. CFRI Program-affiliated R
Page 104 and 105:
100 BRITISH COLUMBIA Quality contro
Page 106 and 107:
102 BRITISH COLUMBIA • Knowledge
Page 108 and 109:
104 Its staffing is as follows: Stu
Page 110 and 111:
106 APPENDIX 3. QUALITY CONTROL/ QU
Page 112 and 113:
APPENDIX 5. CLINICAL TRIALS TRAININ
Page 114 and 115:
APPENDIX 5. Clinical Trials Trainin
Page 116 and 117:
112 APPENDIX 6 TABLE OF CONTENTS BR
Page 118 and 119:
6.1 Clinical Trials Researchers Lis
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225: 6.2 Clinical Trials Researchers Lis
Page 242 and 243: Pediatrics INSTITUTION EMAIL URL DI
Page 244 and 245: Pediatrics (cont’d) INSTITUTION E
Page 252 and 253: 248 APPENDICES 7-13 TABLE OF CONTEN
Page 254 and 255: 250 TABLE A3. Patient and Addiction
Page 256 and 257: 252 TABLE A3. Patient and Addiction
Page 258 and 259: APPENDIX 8. PROVINCIAL AND NATIONAL
Page 260 and 261: APPENDIX 8. Provincial And National
Page 262 and 263: 258 APPENDIX 9. Healthcare Research
Page 264 and 265: APPENDIX 9. Healthcare Research Cen
Page 288 and 289: APPENDIX 10. NATIONAL AND INTERNATI
Page 290 and 291: Networks In Which B.C.’s Clinical
Page 296 and 297: APPENDIX 11. INDEPENDENT CLINICAL T
Page 298 and 299: APPENDIX 11. Independent Clinical T
Page 310 and 311: APPENDIX 12. PRECLINICAL STUDIES SE
Page 312 and 313: APPENDIX 12. Preclinical Studies Se
Page 314 and 315: APPENDIX 12. Preclinical Studies Se
Page 316 and 317: 312 B.C. Centre for Disease Control
Page 318 and 319: 314 University of Victoria Brenda D
Page 320: 316 BRITISH COLUMBIA
show all

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?